|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0000876,
umls-concept:C0001554,
umls-concept:C0005767,
umls-concept:C0006147,
umls-concept:C0014544,
umls-concept:C0016410,
umls-concept:C0027855,
umls-concept:C0032893,
umls-concept:C0032961,
umls-concept:C0033213,
umls-concept:C0038137,
umls-concept:C0039422,
umls-concept:C0039796,
umls-concept:C0042878,
umls-concept:C0043210,
umls-concept:C0175675,
umls-concept:C0282443,
umls-concept:C0332306,
umls-concept:C0441889,
umls-concept:C0549193,
umls-concept:C0684224,
umls-concept:C1273870,
umls-concept:C1519814,
umls-concept:C1552617,
umls-concept:C1706387
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-7-14
|
|
pubmed:abstractText |
To reassess the evidence for management issues related to the care of women with epilepsy (WWE) during pregnancy, including preconceptional folic acid use, prenatal vitamin K use, risk of hemorrhagic disease of the newborn, clinical implications of placental and breast milk transfer of antiepileptic drugs (AEDs), risks of breastfeeding, and change in AED levels during pregnancy.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1526-632X
|
|
pubmed:author |
pubmed-author:American Academy of Neurology,
pubmed-author:American Epilepsy Society,
pubmed-author:FinnellRR,
pubmed-author:FrenchJ AJA,
pubmed-author:GidalBB,
pubmed-author:HardenC LCL,
pubmed-author:HauserW AWA,
pubmed-author:HolmesLL,
pubmed-author:HoppJJ,
pubmed-author:HovingaC ACA,
pubmed-author:KaplanP WPW,
pubmed-author:KoppelB SBS,
pubmed-author:KrumholzAA,
pubmed-author:Le GuenCC,
pubmed-author:MeadorK JKJ,
pubmed-author:PennellP BPB,
pubmed-author:RobinsonJ NJN,
pubmed-author:ShaferP OPO,
pubmed-author:ThurmanDD,
pubmed-author:TingT YTY,
pubmed-author:VazquezBB,
pubmed-author:WiebeSS,
pubmed-author:WilnerA NAN
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
14
|
|
pubmed:volume |
73
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
142-9
|
|
pubmed:dateRevised |
2011-9-22
|
|
pubmed:meshHeading |
pubmed-meshheading:19398680-Anticonvulsants,
pubmed-meshheading:19398680-Breast Feeding,
pubmed-meshheading:19398680-Congenital Abnormalities,
pubmed-meshheading:19398680-Epilepsy,
pubmed-meshheading:19398680-Female,
pubmed-meshheading:19398680-Folic Acid,
pubmed-meshheading:19398680-Humans,
pubmed-meshheading:19398680-Infant, Newborn,
pubmed-meshheading:19398680-Milk, Human,
pubmed-meshheading:19398680-Placenta,
pubmed-meshheading:19398680-Pregnancy,
pubmed-meshheading:19398680-Pregnancy Complications,
pubmed-meshheading:19398680-Risk,
pubmed-meshheading:19398680-Vitamin K,
pubmed-meshheading:19398680-Vitamin K Deficiency Bleeding
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.
|
|
pubmed:affiliation |
University of Miami, Miami, FL, USA.
|
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't,
Practice Guideline
|
